CIDARA THERAPEUTICS INC (CDTX)

US1717572069 - Common Stock

26.62  -0.68 (-2.49%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
26.35M63.91M64.45M49.57M12.07M
Cost Of Goods
N/A1.52M0.00N/AN/A
Gross Profit
N/A62.38M64.45MN/AN/A
Operating Expenses
68.91M86.87M97.95M91.83M83.92M
Research and Development
46.03M68.53M77.41M73.09M68.02M
Selling, General, and Administrative Expenses
22.88M18.33M20.55M18.74M15.90M
Operating Income
-45.26M-24.48M-33.50M-42.26M-71.85M
Interest Income/Expense
4.53M2.00M191.00K-212.00K-262.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-125.62M-22.49M-33.31M-42.47M-72.11M
Income Tax
N/A443.00K272.00KN/AN/A
Net Income
-123.13M-22.93M-33.58M-42.47M-74.87M
EBITDA
-45.05M-24.36M-33.36M-42.07M-71.56M
 
Per Share Data
EPS Diluted Total Ops
-25.94-5.25-9.61-16.19-36.03
Non GAAP EPS
-6.92-4.80-9.60-16.80-36.20
 
Statistics
Gross Profit Margin
N/A97.62%100.00%N/AN/A
Profit Margin
-467.33%-35.88%-52.11%-85.67%-620.48%
Operating Profit Margin
-171.78%-38.31%-51.98%-85.24%-595.42%

All data in USD

Charts